[Study investigating the activity of several fluoroquinolones against Pseudomonas aeruginosa using the mutant prevention concentration].

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 17194384)

Published in Enferm Infecc Microbiol Clin on December 01, 2006

Authors

Elia Sirvent1, Montserrat Ruiz, Juan C Rodríguez, Gloria Royo

Author Affiliations

1: Servicio de Microbiología, Hospital General Universitario de Elche, Universidad Miguel Hernández, Alicante, España.

Articles citing this

[Mutant-prevention concentration: a new, clinically relevant parameter of antimicrobial activity?]. Enferm Infecc Microbiol Clin (2006) 0.75

Articles by these authors

Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin Infect Dis (2003) 2.91

[Health in the immigrant population: prevalence of latent tuberculosis, hepatitis B, hepatitis C, human immunodeficiency virus and syphilis infection]. Enferm Infecc Microbiol Clin (2003) 1.48

The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect (2006) 1.45

[Scientific production in microbiology and affinity areas in Spain during 1990-2002]. Enferm Infecc Microbiol Clin (2005) 1.38

Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol (2011) 1.31

Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test. BMC Infect Dis (2012) 1.15

A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am J Physiol Endocrinol Metab (2008) 1.07

Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy. Hum Mol Genet (2010) 1.03

Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases? Biochim Biophys Acta (2012) 0.99

Mycobacterium marinum infection complicated by anti-tumour necrosis factor therapy. J Med Microbiol (2010) 0.98

Comparison of methods of DNA extraction for real-time PCR in a model of pleural tuberculosis. APMIS (2010) 0.96

[Infection of a spontaneous muscular hematoma due to Robinsoniella peoriensis, in a patient with alcoholic liver cirrhosis]. Enferm Infecc Microbiol Clin (2010) 0.94

Criteria of time and antibiotic susceptibility in the elimination of duplicates when calculating resistance frequencies. J Antimicrob Chemother (2003) 0.91

Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal (2011) 0.90

Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy. Brain (2013) 0.89

Real-time PCR for diagnosing Helicobacter pylori infection in patients with upper gastrointestinal bleeding: comparison with other classical diagnostic methods. J Clin Microbiol (2012) 0.87

Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms. Chemotherapy (2005) 0.87

The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp. Int J Antimicrob Agents (2004) 0.86

Plasmid-mediated quinolone resistance by genes qnrA1 and qnrB19 in Salmonella strains isolated in Brazil. J Infect Dev Ctries (2011) 0.86

Amplified-fragment length polymorphism as a complement to IS6110-based restriction fragment length polymorphism analysis for molecular typing of Mycobacterium tuberculosis. J Clin Microbiol (2003) 0.86

An alternative procedure for preparation of cefdinir. Farmaco (2003) 0.85

Plasmid-mediated quinolone resistance (PMQR) and mutations in the topoisomerase genes of Salmonella enterica strains from Brazil. Braz J Microbiol (2013) 0.84

Prevalence of hepatitis B and C markers in glomerular diseases. Scand J Urol Nephrol (2007) 0.83

Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model. J Antimicrob Chemother (2011) 0.83

Biosorption of Reactive Black 5 from aqueous solutions by chitosan: column studies. J Environ Manage (2010) 0.83

Chagas disease in Latin American pregnant immigrants: experience in a non-endemic country. Arch Gynecol Obstet (2011) 0.82

Replacing the axial ligand tyrosine 75 or its hydrogen bond partner histidine 83 minimally affects hemin acquisition by the hemophore HasAp from Pseudomonas aeruginosa. Biochemistry (2014) 0.81

Seroprevalence of Toxoplasma gondii infection among immigrant and native pregnant women in Eastern Spain. Parasitol Res (2011) 0.81

Mycobacterium abscessus from respiratory isolates: activities of drug combinations. J Infect Chemother (2009) 0.81

Quantification of Helicobacter pylori in gastric mucosa by real-time polymerase chain reaction: comparison with traditional diagnostic methods. Diagn Microbiol Infect Dis (2012) 0.80

Removal of an anionic dye (Acid Blue 92) by coagulation-flocculation using chitosan. J Environ Manage (2009) 0.80

Identification of bacterial DNA in noninfectious pleural fluid with a highly sensitive PCR method. Respiration (2010) 0.80

[Fistula following total laryngectomy. Retrospective study and bibliographical review]. Acta Otorrinolaringol Esp (2009) 0.80

Oxidative stress regulates the ubiquitin-proteasome system and immunoproteasome functioning in a mouse model of X-adrenoleukodystrophy. Brain (2013) 0.80

Analysis of microbiota in stable patients with chronic obstructive pulmonary disease. APMIS (2015) 0.79

Molecular characterization of a Spanish isolate of Mycobacterium malmoense. Res Microbiol (2002) 0.79

Expression and prognostic significance of lysozyme in male breast cancer. Breast Cancer Res (2002) 0.79

Negative effect of immunosuppressive therapy in the performance of the QuantiFERON gold in-tube test in patients with immune-mediated inflammatory diseases. Clin Exp Med (2012) 0.79

In vitro activity of linezolid against Staphylococcus aureus: a population study. Chemotherapy (2005) 0.79

Expression of the marA, soxS, acrB and ramA genes related to the AcrAB/TolC efflux pump in Salmonella enterica strains with and without quinolone resistance-determining regions gyrA gene mutations. Braz J Infect Dis (2013) 0.79

[Expanded-spectrum beta-lactamase-producing strains of E. coli: origin, characteristics and incidence in Southern Alicante (Spain) in the period 1999-2003]. Enferm Infecc Microbiol Clin (2005) 0.78

Predictors of pneumococcal co-infection for patients with pandemic (H1N1) 2009. Emerg Infect Dis (2011) 0.78

[Confounding bias due to indication and severity in observational studies]. Gac Sanit (2011) 0.78

Diabetes mellitus in patients with Alzheimer's disease: clinical description and correlation with the APOE genotype in a sample population from the province of Antioquia, Colombia. Biomedica (2012) 0.77

Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model. APMIS (2011) 0.77

Prevalence of HIV, HBV, HCV, HTLV and Treponema pallidum among patients attending a rural hospital in Southern Ethiopia. J Clin Virol (2011) 0.77

Prevalence of methicillin-resistant Staphylococcus aureus : effect of different criteria for elimination of duplicates. Chemotherapy (2014) 0.77

Relation between induction of the mar operon and cyclohexane tolerance and reduction in fluoroquinolone susceptibility in Salmonella spp. J Infect Chemother (2006) 0.77

The dual role of heme as cofactor and substrate in the biosynthesis of carbon monoxide. Met Ions Life Sci (2009) 0.76

Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy. Acta Neuropathol (2014) 0.75

[Infection due to Mycobacterium kansasii in Elche, Spain]. Med Clin (Barc) (2003) 0.75

Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA). J Cancer Res Clin Oncol (2005) 0.75

Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility. Int J Antimicrob Agents (2004) 0.75

Mycobacterium peregrinum: bactericidal activity of antibiotics alone and in combination. J Infect Chemother (2008) 0.75

[Characterization of gene expression associated with both the AcrAB/TolC system and the membrane permeability, in Salmonella spp isolates with and without gyrA mutation]. Rev Esp Quimioter (2014) 0.75

Mutant prevention concentration: a new tool for choosing treatment in nontuberculous mycobacterial infections. Int J Antimicrob Agents (2004) 0.75

Effect of exposure to fluoroquinolones and beta-lactams on the in vitro activity of other groups of antibiotics in Salmonella spp. APMIS (2006) 0.75

Extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates. Int J Antimicrob Agents (2012) 0.75

In vitro generation of Salmonella spp. mutants following repeated exposure to beta-lactam antibiotics. J Infect Chemother (2006) 0.75

Available options in the management of non-typhi Salmonella. Expert Opin Pharmacother (2004) 0.75

13C NMR spectroscopy of some third-generation cephalosporins, their synthetic intermediaries and reaction byproducts. Magn Reson Chem (2007) 0.75

Analysis of Toxoplasma gondii surface antigen 2 gene (SAG2). Relevance of genotype I in clinical toxoplasmosis. Mol Biol Rep (2009) 0.75

[Legionella pneumophila in community acquired pneumonia: interpretation of microbiological techniques]. Med Clin (Barc) (2004) 0.75

[Genomic typing of M. tuberculosis strains with few IS6110 copies: usefulness of amplified fragment length polymorphism (AFLP), variable number tandem repeat (VNTR) and spoligotyping]. Med Clin (Barc) (2005) 0.75

Fluoroquinolone resistance in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates. J Antimicrob Chemother (2011) 0.75